1 | chemotherapy | 23,199 |
2 | chemotherapies | 165 |
3 | polychemotherapy | 138 |
4 | doublets | 130 |
5 | immunochemotherapy | 75 |
6 | biochemotherapy | 49 |
7 | biotherapy | 22 |
8 | chemolipiodolization | 12 |
9 | chemotherapy/radiotherapy | 11 |
10 | ifn-alpha-2a | 11 |
11 | chemo-therapy | 10 |
12 | chemo/radiotherapy | 9 |
13 | doxorubicin-cyclophosphamide | 8 |
14 | hai-fudr | 8 |
15 | cisplatin-vinorelbine | 7 |
16 | hormone-therapy | 7 |
17 | capecitabine/erlotinib | 6 |
18 | epirubicin/cyclophosphamide | 6 |
19 | iaacnu | 6 |
20 | iodine-131-lipiodol | 6 |
21 | s-paclitaxel | 6 |
22 | who-mdt | 6 |
23 | atropinization | 5 |
24 | chemoimmunotherapies | 5 |
25 | chemotherapy+rh-endostatin | 5 |
26 | chth | 5 |
27 | hdit/hct | 5 |
28 | stent-angioplasty | 5 |
29 | valsartan-amlodipine | 5 |
30 | ac-doc | 4 |
31 | cciv/tiv | 4 |
32 | ct/trt | 4 |
33 | estrogen-progestins | 4 |
34 | fulvenes | 4 |
35 | pegifnα/ribavirin | 4 |
36 | rivax | 4 |
37 | targeted-therapy | 4 |
38 | 'hwe | 3 |
39 | 5fu/fa | 3 |
40 | acei/aras | 3 |
41 | atiii/heparin | 3 |
42 | bms-986094 | 3 |
43 | cisplatin-cyclophosphamide | 3 |
44 | docetaxel-epirubicin | 3 |
45 | gentamicin/metronidazole | 3 |
46 | hemotherapy | 3 |
47 | immunoablation | 3 |
48 | nascn | 3 |
49 | nitrosospecies | 3 |
50 | ppc-1 | 3 |
51 | tese-icsi | 3 |
52 | training/competition | 3 |
53 | 20gy | 2 |
54 | 2g-tkis | 2 |
55 | 5-fu/oxaliplatin | 2 |
56 | adriamycin/cyclophosphamide | 2 |
57 | arb-ccb | 2 |
58 | as04c | 2 |
59 | axitinib/paclitaxel/carboplatin | 2 |
60 | bevacizumab-chemotherapy | 2 |
61 | bupvicaine | 2 |
62 | caf01 | 2 |
63 | caffeine/ephedrine | 2 |
64 | caobenjuan | 2 |
65 | ceftazidime-trimethoprim-sulphamethoxazole | 2 |
66 | chemotheraphy | 2 |
67 | chemotherapy/immunotherapy | 2 |
68 | cisplatin-docetaxel | 2 |
69 | cisplatin/radiotherapy | 2 |
70 | cisplatin/vepesid | 2 |
71 | ddp/5-fu | 2 |
72 | duloxetine-methadone | 2 |
73 | fu/ox | 2 |
74 | ge/as01 | 2 |
75 | gemcitabine-combination | 2 |
76 | ghr+phosphate | 2 |
77 | hne1 | 2 |
78 | induced-arthritis | 2 |
79 | isosorbide-dinitrate/hydralazine | 2 |
80 | misoprostol-alone | 2 |
81 | mono-chemotherapy | 2 |
82 | non-eiaeds | 2 |
83 | preauthorizations | 2 |
84 | sorafenib/bevacizumab | 2 |
85 | spironolactone/furosemide | 2 |
86 | taxane-anthracycline | 2 |
87 | thionamides | 2 |
88 | trastuzumab-docetaxel | 2 |
89 | who-pb-mdt | 2 |
90 | 'chemotherapy-only | 1 |
91 | 1st-line-chemotherapy | 1 |
92 | 3d-plus-ribavirin | 1 |
93 | 6-mp/mtx | 1 |
94 | 7-day-week | 1 |
95 | 8-week-outpatient | 1 |
96 | adoc-schedule | 1 |
97 | aliskirin | 1 |
98 | amyloidosis-53 | 1 |
99 | analyses.cot | 1 |
100 | anthracyclines-containing | 1 |
101 | arbmedication | 1 |
102 | artv | 1 |
103 | bevacizumab-folfox-4 | 1 |
104 | bromonitromethane | 1 |
105 | capox±cetuximab | 1 |
106 | celanide | 1 |
107 | chemo-endocrinotherapy | 1 |
108 | chemo-hormonotherapy | 1 |
109 | chemotherapy-doublet | 1 |
110 | chemotherapy-gemcitabine | 1 |
111 | chemotherapy.according | 1 |
112 | chemotherapy.treatment | 1 |
113 | chemothery | 1 |
114 | chemothetherapy | 1 |
115 | cisplatin-gemcitabine-paclitaxel | 1 |
116 | combination-chemotherapy | 1 |
117 | combo® | 1 |
118 | consolidation/intensification | 1 |
119 | contrariis | 1 |
120 | cpt-11/5-fu/leucovirin | 1 |
121 | crt-i+sh | 1 |
122 | diclofenace | 1 |
123 | docetaxel/gvax | 1 |
124 | energy-depriving | 1 |
125 | epirubicin-docetaxel | 1 |
126 | epirubicin-paclitaxel | 1 |
127 | euihak | 1 |
128 | fluoro-pyrimidine | 1 |
129 | fluoropirimidine | 1 |
130 | ftorafur-containing | 1 |
131 | glipressina | 1 |
132 | high-dose-poly-chth | 1 |
133 | hormono-radiotherapy | 1 |
134 | hydralazine-nitrate | 1 |
135 | icds/crt-ds | 1 |
136 | intavitral | 1 |
137 | linaglitpin | 1 |
138 | lsa2l2 | 1 |
139 | methotrexate-vinblastine-doxorubicin-cisplatin | 1 |
140 | mk-5172-based | 1 |
141 | nl-17 | 1 |
142 | nnrti-nrti | 1 |
143 | nonyl-phenoxy-poly | 1 |
144 | packed-red-cell | 1 |
145 | paclitaxel+carboplatin+bevacizumab | 1 |
146 | paclitaxel/carboplatin/sorafenib | 1 |
147 | picmecillinam | 1 |
148 | polychemotherapeutics | 1 |
149 | polymediation | 1 |
150 | s-1/carboplatin | 1 |
151 | solution/flush | 1 |
152 | synsorb-pk | 1 |
153 | taxane-/anthracycline-based | 1 |
154 | tenofovir/emtricitabine-based | 1 |
155 | therapy-chemotherapy | 1 |
156 | therapy.direct | 1 |
157 | therapy.indirect | 1 |
158 | therapy.os | 1 |
159 | tivo-1 | 1 |
160 | trastuzmab | 1 |
161 | treatment-is | 1 |
162 | treatment.am | 1 |
163 | uft/leucovorin/irinotecan | 1 |
164 | vcmp/vbap | 1 |
165 | vegf-inhibitor | 1 |
166 | vinorebine | 1 |
167 | xeromammogram | 1 |
168 | ymbs | 1 |
169 | zdv/ddi- | 1 |
1 | 'chemotherapy-only | 1 |
2 | 'hwe | 3 |
3 | 1st-line-chemotherapy | 1 |
4 | 20gy | 2 |
5 | 2g-tkis | 2 |
6 | 3d-plus-ribavirin | 1 |
7 | 5-fu/oxaliplatin | 2 |
8 | 5fu/fa | 3 |
9 | 6-mp/mtx | 1 |
10 | 7-day-week | 1 |
11 | 8-week-outpatient | 1 |
12 | ac-doc | 4 |
13 | acei/aras | 3 |
14 | adoc-schedule | 1 |
15 | adriamycin/cyclophosphamide | 2 |
16 | aliskirin | 1 |
17 | amyloidosis-53 | 1 |
18 | analyses.cot | 1 |
19 | anthracyclines-containing | 1 |
20 | arb-ccb | 2 |
21 | arbmedication | 1 |
22 | artv | 1 |
23 | as04c | 2 |
24 | atiii/heparin | 3 |
25 | atropinization | 5 |
26 | axitinib/paclitaxel/carboplatin | 2 |
27 | bevacizumab-chemotherapy | 2 |
28 | bevacizumab-folfox-4 | 1 |
29 | biochemotherapy | 49 |
30 | biotherapy | 22 |
31 | bms-986094 | 3 |
32 | bromonitromethane | 1 |
33 | bupvicaine | 2 |
34 | caf01 | 2 |
35 | caffeine/ephedrine | 2 |
36 | caobenjuan | 2 |
37 | capecitabine/erlotinib | 6 |
38 | capox±cetuximab | 1 |
39 | cciv/tiv | 4 |
40 | ceftazidime-trimethoprim-sulphamethoxazole | 2 |
41 | celanide | 1 |
42 | chemo-endocrinotherapy | 1 |
43 | chemo-hormonotherapy | 1 |
44 | chemo-therapy | 10 |
45 | chemo/radiotherapy | 9 |
46 | chemoimmunotherapies | 5 |
47 | chemolipiodolization | 12 |
48 | chemotheraphy | 2 |
49 | chemotherapies | 165 |
50 | chemotherapy | 23,199 |
51 | chemotherapy+rh-endostatin | 5 |
52 | chemotherapy-doublet | 1 |
53 | chemotherapy-gemcitabine | 1 |
54 | chemotherapy.according | 1 |
55 | chemotherapy.treatment | 1 |
56 | chemotherapy/immunotherapy | 2 |
57 | chemotherapy/radiotherapy | 11 |
58 | chemothery | 1 |
59 | chemothetherapy | 1 |
60 | chth | 5 |
61 | cisplatin-cyclophosphamide | 3 |
62 | cisplatin-docetaxel | 2 |
63 | cisplatin-gemcitabine-paclitaxel | 1 |
64 | cisplatin-vinorelbine | 7 |
65 | cisplatin/radiotherapy | 2 |
66 | cisplatin/vepesid | 2 |
67 | combination-chemotherapy | 1 |
68 | combo® | 1 |
69 | consolidation/intensification | 1 |
70 | contrariis | 1 |
71 | cpt-11/5-fu/leucovirin | 1 |
72 | crt-i+sh | 1 |
73 | ct/trt | 4 |
74 | ddp/5-fu | 2 |
75 | diclofenace | 1 |
76 | docetaxel-epirubicin | 3 |
77 | docetaxel/gvax | 1 |
78 | doublets | 130 |
79 | doxorubicin-cyclophosphamide | 8 |
80 | duloxetine-methadone | 2 |
81 | energy-depriving | 1 |
82 | epirubicin-docetaxel | 1 |
83 | epirubicin-paclitaxel | 1 |
84 | epirubicin/cyclophosphamide | 6 |
85 | estrogen-progestins | 4 |
86 | euihak | 1 |
87 | fluoro-pyrimidine | 1 |
88 | fluoropirimidine | 1 |
89 | ftorafur-containing | 1 |
90 | fu/ox | 2 |
91 | fulvenes | 4 |
92 | ge/as01 | 2 |
93 | gemcitabine-combination | 2 |
94 | gentamicin/metronidazole | 3 |
95 | ghr+phosphate | 2 |
96 | glipressina | 1 |
97 | hai-fudr | 8 |
98 | hdit/hct | 5 |
99 | hemotherapy | 3 |
100 | high-dose-poly-chth | 1 |
101 | hne1 | 2 |
102 | hormone-therapy | 7 |
103 | hormono-radiotherapy | 1 |
104 | hydralazine-nitrate | 1 |
105 | iaacnu | 6 |
106 | icds/crt-ds | 1 |
107 | ifn-alpha-2a | 11 |
108 | immunoablation | 3 |
109 | immunochemotherapy | 75 |
110 | induced-arthritis | 2 |
111 | intavitral | 1 |
112 | iodine-131-lipiodol | 6 |
113 | isosorbide-dinitrate/hydralazine | 2 |
114 | linaglitpin | 1 |
115 | lsa2l2 | 1 |
116 | methotrexate-vinblastine-doxorubicin-cisplatin | 1 |
117 | misoprostol-alone | 2 |
118 | mk-5172-based | 1 |
119 | mono-chemotherapy | 2 |
120 | nascn | 3 |
121 | nitrosospecies | 3 |
122 | nl-17 | 1 |
123 | nnrti-nrti | 1 |
124 | non-eiaeds | 2 |
125 | nonyl-phenoxy-poly | 1 |
126 | packed-red-cell | 1 |
127 | paclitaxel+carboplatin+bevacizumab | 1 |
128 | paclitaxel/carboplatin/sorafenib | 1 |
129 | pegifnα/ribavirin | 4 |
130 | picmecillinam | 1 |
131 | polychemotherapeutics | 1 |
132 | polychemotherapy | 138 |
133 | polymediation | 1 |
134 | ppc-1 | 3 |
135 | preauthorizations | 2 |
136 | rivax | 4 |
137 | s-1/carboplatin | 1 |
138 | s-paclitaxel | 6 |
139 | solution/flush | 1 |
140 | sorafenib/bevacizumab | 2 |
141 | spironolactone/furosemide | 2 |
142 | stent-angioplasty | 5 |
143 | synsorb-pk | 1 |
144 | targeted-therapy | 4 |
145 | taxane-/anthracycline-based | 1 |
146 | taxane-anthracycline | 2 |
147 | tenofovir/emtricitabine-based | 1 |
148 | tese-icsi | 3 |
149 | therapy-chemotherapy | 1 |
150 | therapy.direct | 1 |
151 | therapy.indirect | 1 |
152 | therapy.os | 1 |
153 | thionamides | 2 |
154 | tivo-1 | 1 |
155 | training/competition | 3 |
156 | trastuzmab | 1 |
157 | trastuzumab-docetaxel | 2 |
158 | treatment-is | 1 |
159 | treatment.am | 1 |
160 | uft/leucovorin/irinotecan | 1 |
161 | valsartan-amlodipine | 5 |
162 | vcmp/vbap | 1 |
163 | vegf-inhibitor | 1 |
164 | vinorebine | 1 |
165 | who-mdt | 6 |
166 | who-pb-mdt | 2 |
167 | xeromammogram | 1 |
168 | ymbs | 1 |
169 | zdv/ddi- | 1 |
1 | zdv/ddi- | 1 |
2 | ppc-1 | 3 |
3 | tivo-1 | 1 |
4 | caf01 | 2 |
5 | ge/as01 | 2 |
6 | hne1 | 2 |
7 | lsa2l2 | 1 |
8 | amyloidosis-53 | 1 |
9 | bevacizumab-folfox-4 | 1 |
10 | bms-986094 | 3 |
11 | nl-17 | 1 |
12 | ifn-alpha-2a | 11 |
13 | 5fu/fa | 3 |
14 | glipressina | 1 |
15 | capox±cetuximab | 1 |
16 | paclitaxel+carboplatin+bevacizumab | 1 |
17 | sorafenib/bevacizumab | 2 |
18 | trastuzmab | 1 |
19 | arb-ccb | 2 |
20 | paclitaxel/carboplatin/sorafenib | 1 |
21 | capecitabine/erlotinib | 6 |
22 | as04c | 2 |
23 | ac-doc | 4 |
24 | mk-5172-based | 1 |
25 | tenofovir/emtricitabine-based | 1 |
26 | taxane-/anthracycline-based | 1 |
27 | cisplatin/vepesid | 2 |
28 | diclofenace | 1 |
29 | doxorubicin-cyclophosphamide | 8 |
30 | cisplatin-cyclophosphamide | 3 |
31 | epirubicin/cyclophosphamide | 6 |
32 | adriamycin/cyclophosphamide | 2 |
33 | spironolactone/furosemide | 2 |
34 | celanide | 1 |
35 | gentamicin/metronidazole | 3 |
36 | ceftazidime-trimethoprim-sulphamethoxazole | 2 |
37 | adoc-schedule | 1 |
38 | bromonitromethane | 1 |
39 | bupvicaine | 2 |
40 | chemotherapy-gemcitabine | 1 |
41 | vinorebine | 1 |
42 | cisplatin-vinorelbine | 7 |
43 | fluoropirimidine | 1 |
44 | fluoro-pyrimidine | 1 |
45 | taxane-anthracycline | 2 |
46 | valsartan-amlodipine | 5 |
47 | caffeine/ephedrine | 2 |
48 | isosorbide-dinitrate/hydralazine | 2 |
49 | duloxetine-methadone | 2 |
50 | misoprostol-alone | 2 |
51 | ghr+phosphate | 2 |
52 | hydralazine-nitrate | 1 |
53 | 'hwe | 3 |
54 | chemotherapy.according | 1 |
55 | ftorafur-containing | 1 |
56 | anthracyclines-containing | 1 |
57 | energy-depriving | 1 |
58 | crt-i+sh | 1 |
59 | solution/flush | 1 |
60 | chth | 5 |
61 | high-dose-poly-chth | 1 |
62 | tese-icsi | 3 |
63 | nnrti-nrti | 1 |
64 | euihak | 1 |
65 | 7-day-week | 1 |
66 | synsorb-pk | 1 |
67 | intavitral | 1 |
68 | trastuzumab-docetaxel | 2 |
69 | epirubicin-docetaxel | 1 |
70 | cisplatin-docetaxel | 2 |
71 | cisplatin-gemcitabine-paclitaxel | 1 |
72 | epirubicin-paclitaxel | 1 |
73 | s-paclitaxel | 6 |
74 | packed-red-cell | 1 |
75 | iodine-131-lipiodol | 6 |
76 | treatment.am | 1 |
77 | picmecillinam | 1 |
78 | xeromammogram | 1 |
79 | uft/leucovorin/irinotecan | 1 |
80 | caobenjuan | 2 |
81 | nascn | 3 |
82 | docetaxel-epirubicin | 3 |
83 | linaglitpin | 1 |
84 | atiii/heparin | 3 |
85 | aliskirin | 1 |
86 | 3d-plus-ribavirin | 1 |
87 | pegifnα/ribavirin | 4 |
88 | cpt-11/5-fu/leucovirin | 1 |
89 | 5-fu/oxaliplatin | 2 |
90 | s-1/carboplatin | 1 |
91 | axitinib/paclitaxel/carboplatin | 2 |
92 | methotrexate-vinblastine-doxorubicin-cisplatin | 1 |
93 | chemotherapy+rh-endostatin | 5 |
94 | arbmedication | 1 |
95 | consolidation/intensification | 1 |
96 | polymediation | 1 |
97 | immunoablation | 3 |
98 | gemcitabine-combination | 2 |
99 | chemolipiodolization | 12 |
100 | atropinization | 5 |
101 | training/competition | 3 |
102 | vcmp/vbap | 1 |
103 | hai-fudr | 8 |
104 | vegf-inhibitor | 1 |
105 | acei/aras | 3 |
106 | ymbs | 1 |
107 | polychemotherapeutics | 1 |
108 | icds/crt-ds | 1 |
109 | non-eiaeds | 2 |
110 | thionamides | 2 |
111 | nitrosospecies | 3 |
112 | chemotherapies | 165 |
113 | chemoimmunotherapies | 5 |
114 | fulvenes | 4 |
115 | treatment-is | 1 |
116 | contrariis | 1 |
117 | 2g-tkis | 2 |
118 | induced-arthritis | 2 |
119 | estrogen-progestins | 4 |
120 | preauthorizations | 2 |
121 | therapy.os | 1 |
122 | doublets | 130 |
123 | therapy.direct | 1 |
124 | therapy.indirect | 1 |
125 | hdit/hct | 5 |
126 | who-pb-mdt | 2 |
127 | who-mdt | 6 |
128 | chemotherapy-doublet | 1 |
129 | 8-week-outpatient | 1 |
130 | chemotherapy.treatment | 1 |
131 | analyses.cot | 1 |
132 | ct/trt | 4 |
133 | ddp/5-fu | 2 |
134 | iaacnu | 6 |
135 | cciv/tiv | 4 |
136 | artv | 1 |
137 | docetaxel/gvax | 1 |
138 | rivax | 4 |
139 | fu/ox | 2 |
140 | 6-mp/mtx | 1 |
141 | 20gy | 2 |
142 | chemotheraphy | 2 |
143 | 'chemotherapy-only | 1 |
144 | nonyl-phenoxy-poly | 1 |
145 | targeted-therapy | 4 |
146 | hormone-therapy | 7 |
147 | chemo-therapy | 10 |
148 | chemothetherapy | 1 |
149 | biotherapy | 22 |
150 | hormono-radiotherapy | 1 |
151 | cisplatin/radiotherapy | 2 |
152 | chemo/radiotherapy | 9 |
153 | chemotherapy/radiotherapy | 11 |
154 | hemotherapy | 3 |
155 | chemotherapy | 23,199 |
156 | bevacizumab-chemotherapy | 2 |
157 | 1st-line-chemotherapy | 1 |
158 | combination-chemotherapy | 1 |
159 | mono-chemotherapy | 2 |
160 | therapy-chemotherapy | 1 |
161 | biochemotherapy | 49 |
162 | immunochemotherapy | 75 |
163 | polychemotherapy | 138 |
164 | chemo-endocrinotherapy | 1 |
165 | chemo-hormonotherapy | 1 |
166 | chemotherapy/immunotherapy | 2 |
167 | chemothery | 1 |
168 | stent-angioplasty | 5 |
169 | combo® | 1 |